9CGD
 
 | Human DJ-1, 10 sec mixing with methylglyoxal, pink beam time-resolved serial crystallography, CrystFEL processed | Descriptor: | Parkinson disease protein 7 | Authors: | Zielinski, K, Dolamore, C, Dalton, K, Meisburger, S, Smith, N, Termini, J, Henning, R, Srajer, V, Hekstra, D, Pollack, L, Wilson, M.A. | Deposit date: | 2024-06-28 | Release date: | 2025-03-12 | Method: | X-RAY DIFFRACTION (1.97 Å) | Cite: | Resolving DJ-1 Glyoxalase Catalysis Using Mix-and-Inject Serial Crystallography at a Synchrotron. Biorxiv, 2024
|
|
9CGE
 
 | Human DJ-1, 15 sec mixing with methylglyoxal, pink beam time-resolved serial crystallography, CrystFEL processed | Descriptor: | Parkinson disease protein 7 | Authors: | Zielinski, K, Dolamore, C, Dalton, K, Meisburger, S, Smith, N, Termini, J, Henning, R, Srajer, V, Hekstra, D, Pollack, L, Wilson, M.A. | Deposit date: | 2024-06-28 | Release date: | 2025-03-12 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Resolving DJ-1 Glyoxalase Catalysis Using Mix-and-Inject Serial Crystallography at a Synchrotron. Biorxiv, 2024
|
|
7TIF
 
 | |
9GOK
 
 | X-ray structure of lysozyme obtained upon reaction with the dioxidovanadium(V) complex with (E)-N'-(1-(2-hydroxy-5-methoxyphenyl)ethylidene)furan-2-carbohydrazide) | Descriptor: | ACETATE ION, CHLORIDE ION, Lysozyme C, ... | Authors: | Paolillo, M, Ferraro, G, Merlino, A. | Deposit date: | 2024-09-05 | Release date: | 2024-12-18 | Method: | X-RAY DIFFRACTION (1.18 Å) | Cite: | Interaction of V V O 2 -hydrazonates with lysozyme. J.Inorg.Biochem., 264, 2024
|
|
9CFY
 
 | Human DJ-1, 15 sec mixing with methylglyoxal, pink beam time-resolved serial crystallography | Descriptor: | Parkinson disease protein 7 | Authors: | Zielinski, K.A, Dolamore, C, Dalton, K, Meisburger, S.P, Smith, N, Termini, T, Henning, R, Srajer, V, Hekstra, D, Pollack, L, Wilson, M.A. | Deposit date: | 2024-06-27 | Release date: | 2025-03-12 | Method: | X-RAY DIFFRACTION (1.77 Å) | Cite: | Resolving DJ-1 Glyoxalase Catalysis Using Mix-and-Inject Serial Crystallography at a Synchrotron. Biorxiv, 2024
|
|
9CG0
 
 | Human DJ-1, 30 sec mixing with methylglyoxal, pink beam time-resolved serial crystallography | Descriptor: | Parkinson disease protein 7 | Authors: | Zielinski, K.A, Dolamore, C, Dalton, K, Meisburger, S.P, Smith, N, Termini, J, Henning, R, Srajer, V, Hekstra, D, Pollack, L, Wilson, M.A. | Deposit date: | 2024-06-28 | Release date: | 2025-03-12 | Method: | X-RAY DIFFRACTION (1.77 Å) | Cite: | Resolving DJ-1 Glyoxalase Catalysis Using Mix-and-Inject Serial Crystallography at a Synchrotron. Biorxiv, 2024
|
|
9CGG
 
 | Human DJ-1, 30 sec mixing with methylglyoxal, pink beam time-resolved serial crystallography, CrystFEL processed | Descriptor: | Parkinson disease protein 7 | Authors: | Zielinski, K, Dolamore, C, Dalton, K, Meisburger, S, Smith, N, Termini, J, Henning, R, Srajer, V, Hekstra, D, Pollack, L, Wilson, M.A. | Deposit date: | 2024-06-28 | Release date: | 2025-03-12 | Method: | X-RAY DIFFRACTION (2.01 Å) | Cite: | Resolving DJ-1 Glyoxalase Catalysis Using Mix-and-Inject Serial Crystallography at a Synchrotron. Biorxiv, 2024
|
|
9CEI
 
 | Human DJ-1, no mixing, pink beam time-resolved serial crystallography | Descriptor: | Parkinson disease protein 7 | Authors: | Zielinski, K.A, Dolamore, C, Dalton, K, Meisburger, S.P, Smith, N, Termini, J, Henning, R, Srajer, V, Hekstra, D, Pollack, L, Wilson, M.A. | Deposit date: | 2024-06-26 | Release date: | 2025-03-12 | Method: | X-RAY DIFFRACTION (1.77 Å) | Cite: | Resolving DJ-1 Glyoxalase Catalysis Using Mix-and-Inject Serial Crystallography at a Synchrotron. Biorxiv, 2024
|
|
7BXA
 
 | Crystal structure of PD-1 in complex with tislelizumab Fab | Descriptor: | Programmed cell death protein 1, heavy chain, light chain | Authors: | Heo, Y.S, Lee, S.H, Lim, H, Lee, H.T, Kim, Y.J, Park, E.B. | Deposit date: | 2020-04-18 | Release date: | 2020-06-10 | Last modified: | 2024-11-13 | Method: | X-RAY DIFFRACTION (3.32 Å) | Cite: | Crystal structure of PD-1 in complex with an antibody-drug tislelizumab used in tumor immune checkpoint therapy. Biochem.Biophys.Res.Commun., 527, 2020
|
|
7BTS
 
 | Structure of human beta1 adrenergic receptor bound to epinephrine and nanobody 6B9 | Descriptor: | (2S)-2,3-dihydroxypropyl (7Z)-tetradec-7-enoate, 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, CHOLESTEROL, ... | Authors: | Xu, X, Kaindl, J, Clark, M, Hubner, H, Hirata, K, Sunahara, R, Gmeiner, P, Kobilka, B.K, Liu, X. | Deposit date: | 2020-04-02 | Release date: | 2020-12-02 | Last modified: | 2024-10-30 | Method: | X-RAY DIFFRACTION (3.13 Å) | Cite: | Binding pathway determines norepinephrine selectivity for the human beta 1 AR over beta 2 AR. Cell Res., 31, 2021
|
|
6B96
 
 | Crystal Structure of PDE2 in complex with compound 16 | Descriptor: | 1,2-ETHANEDIOL, 6-chloro-N-{1-[4-(trifluoromethyl)phenyl]cyclopropyl}-1H-pyrazolo[3,4-d]pyrimidin-4-amine, MAGNESIUM ION, ... | Authors: | Lu, J. | Deposit date: | 2017-10-10 | Release date: | 2017-11-22 | Last modified: | 2024-03-06 | Method: | X-RAY DIFFRACTION (1.88 Å) | Cite: | The identification of a novel lead class for phosphodiesterase 2 inhibition by fragment-based drug design. Bioorg. Med. Chem. Lett., 27, 2017
|
|
9MDT
 
 | |
9MED
 
 | |
9MF6
 
 | |
9CFQ
 
 | Human DJ-1, no mixing, pink beam time-resolved serial crystallography, CrystFEL processed | Descriptor: | Parkinson disease protein 7 | Authors: | Zielinski, K, Dolamore, C, Dalton, K, Meisburger, S, Smith, N, Termini, J, Henning, R, Srajer, V, Hekstra, D, Pollack, L, Wilson, M.A. | Deposit date: | 2024-06-27 | Release date: | 2025-03-12 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Resolving DJ-1 Glyoxalase Catalysis Using Mix-and-Inject Serial Crystallography at a Synchrotron. Biorxiv, 2024
|
|
9CMX
 
 | Human DJ-1, fixed target serial crystallography | Descriptor: | Parkinson disease protein 7 | Authors: | Zielinski, K, Dolamore, C, Dalton, K, Meisburger, S, Smith, N, Termini, J, Henning, R, Srajer, V, Hekstra, D, Pollack, L, Wilson, M.A. | Deposit date: | 2024-07-15 | Release date: | 2025-03-12 | Method: | X-RAY DIFFRACTION (1.63 Å) | Cite: | Resolving DJ-1 Glyoxalase Catalysis Using Mix-and-Inject Serial Crystallography at a Synchrotron. Biorxiv, 2024
|
|
9GNG
 
 | mouse VDAC1 in complex with MPD | Descriptor: | (4S)-2-METHYL-2,4-PENTANEDIOL, 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE, Isoform Mt-VDAC1 of Non-selective voltage-gated ion channel VDAC1 | Authors: | Lolicato, M, Arrigoni, C. | Deposit date: | 2024-09-03 | Release date: | 2025-01-08 | Last modified: | 2025-01-22 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | Protocol for high-yield bacterial expression and purification of the voltage-dependent anion channel 1 for high-throughput biophysical assays. STAR Protoc, 6, 2025
|
|
6GQP
 
 | Crystal structure of human KDR (VEGFR2) kinase domain in complex with AZD3229-analogue (compound 23) | Descriptor: | Vascular endothelial growth factor receptor 2, ~{N}-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]-2-(1-ethylpyrazol-4-yl)ethanamide | Authors: | Hardy, C.J, Schimpl, M, Ogg, D.J, Overman, R.C, Packer, M.J, Kettle, J.G, Anjum, R, Barry, E, Bhavsar, D, Brown, C, Campbell, A, Goldberg, K, Grondine, M, Guichard, S, Hunt, T, Jones, O, Li, X, Moleva, O, Pearson, S, Shao, W, Smith, A, Smith, J, Stead, D, Stokes, S, Tucker, M, Ye, Y. | Deposit date: | 2018-06-07 | Release date: | 2018-09-19 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (2.09 Å) | Cite: | Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1 H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal Tumors. J. Med. Chem., 61, 2018
|
|
7XB8
 
 | |
7XB7
 
 | Phosphoglycerate mutase 1 complexed with a covalent inhibitor | Descriptor: | 3-[[5-(cyclopenten-1-yl)-2-(methylcarbamoyl)phenyl]sulfamoyl]benzenesulfonic acid, CHLORIDE ION, Phosphoglycerate mutase 1 | Authors: | Jiang, L.L, Zhou, L. | Deposit date: | 2022-03-21 | Release date: | 2023-09-27 | Last modified: | 2024-11-20 | Method: | X-RAY DIFFRACTION (2.2 Å) | Cite: | Phosphoglycerate mutase 1 complexed with a covalent inhibitor To Be Published
|
|
7XB9
 
 | Phosphoglycerate mutase 1 complexed with a covalent inhibitor | Descriptor: | 3-[[5-(cyclopenten-1-yl)-2-methoxycarbonyl-phenyl]sulfamoyl]benzenesulfonic acid, CHLORIDE ION, Phosphoglycerate mutase 1 | Authors: | Jiang, L.L, Zhou, L. | Deposit date: | 2022-03-21 | Release date: | 2023-09-27 | Last modified: | 2024-10-09 | Method: | X-RAY DIFFRACTION (1.58 Å) | Cite: | Phosphoglycerate mutase 1 complexed with a covalent inhibitor To Be Published
|
|
9D50
 
 | Structure of PAK1 in complex with compound 24 | Descriptor: | 3-cyano-N-[3-({6-[(5-cyclopropyl-1,3-thiazol-2-yl)amino]pyrazin-2-yl}amino)bicyclo[1.1.1]pentan-1-yl]azetidine-3-carboxamide, Serine/threonine-protein kinase PAK 1 | Authors: | Fontano, E, Suto, R.K, Olland, A.M. | Deposit date: | 2024-08-13 | Release date: | 2025-04-02 | Last modified: | 2025-07-16 | Method: | X-RAY DIFFRACTION (1.898 Å) | Cite: | Identification of a p21-activated kinase 1 (PAK1) inhibitor with 10-fold selectivity against PAK2. Bioorg.Med.Chem.Lett., 127, 2025
|
|
6GQ9
 
 | |
5N7G
 
 | MAGI-1 complexed with a synthetic pRSK1 peptide | Descriptor: | CALCIUM ION, GLYCEROL, Membrane-associated guanylate kinase, ... | Authors: | Gogl, G, Nyitray, L. | Deposit date: | 2017-02-20 | Release date: | 2017-11-08 | Last modified: | 2024-11-13 | Method: | X-RAY DIFFRACTION (2.95 Å) | Cite: | Dynamic control of RSK complexes by phosphoswitch-based regulation. FEBS J., 285, 2018
|
|
4AZ6
 
 | Differential inhibition of the tandem GH20 catalytic modules in the pneumococcal exo-beta-D-N-acetylglucosaminidase, StrH | Descriptor: | 1,2-ETHANEDIOL, 2,5,8,11,14,17-HEXAOXANONADECAN-19-OL, BETA-N-ACETYLHEXOSAMINIDASE, ... | Authors: | Pluvinage, B, Stubbs, K.A, Vocadlo, D.J, Boraston, A.B. | Deposit date: | 2012-06-23 | Release date: | 2013-07-10 | Last modified: | 2023-12-20 | Method: | X-RAY DIFFRACTION (1.36 Å) | Cite: | Inhibition of the Family 20 Glycoside Hydrolase Catalytic Modules in the Streptococcus Pneumoniae Exo-Beta-D-N-Acetylglucosaminidase, Strh. Org.Biomol.Chem., 11, 2013
|
|